Lawrence Panasci

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 08, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

John F R Robertson, Zhimin Shao, Shinzaburo Noguchi

|Aug 19, 2021
The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature.

François Panet, Marianne Tétreault-Langlois, Vincent Morin

|Jul 25, 2018
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.

Bahram Sharif-Askari, Lilian Amrein, Raquel Aloyz

Pageof 1